Evaluation of the quick diagnosis and treatment program for lung cancer

被引:1
作者
Granell, E. [1 ]
Hidalgo, A. [1 ]
Martinez, A. [1 ]
Gich, I. [2 ]
Bolivar, I. [2 ]
Franquet, T. [1 ]
Gimenez, A. [1 ]
Alepuz, T. [2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Radiodiagnost, Barcelona, Spain
[2] Hosp La Santa Creu & Sant Pau, Serv Epidemiol, Barcelona, Spain
来源
RADIOLOGIA | 2009年 / 51卷 / 03期
关键词
Lung cancer; Quick diagnosis; Quick treatment; Prognosis;
D O I
10.1016/j.rx.2008.10.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To analyze the efficiency of the program of quick diagnosis and treatment (PDTR, programa de diagnostico y tratamiento rapido) of lung cancer established in the Hospital de la Santa Creu i Sant Pau of Barcelona to review the epidemiology of lung cancer. Methods and materials: Fifty-eight patients with lung cancer were studied. Twenty-nine of them were included in the program between October 2005 and May 2006, and the remaining were randomly selected among those diagnosed the year before (control group). Time between first visit, diagnosis and treatment and other variables (age, sex, histological type and TNM stage) were compared between groups. Results: Significant differences were found between the two groups. PDTR patients had a mean time between first visit and treatment of 26.7 days (Standard Deviation [SD] = 13.6), whereas this was 84 days (SD = 53) in the control group. The PDTR group had a lower TNM stage, but statistical significance was only found in N (lymph node involvement) (p = 0.007). Conclusion: Most patients included in the PDTR program spend less than 30 days between first visit and treatment, which represents a significant reduction in time (p <0.001). The effect on prognosis is controversial and will need long term studies. (C) 2007 SERAM. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 50 条
[21]   Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis [J].
Pei, Qin ;
Luo, Yanan ;
Chen, Yiyu ;
Li, Jingyuan ;
Xie, Dan ;
Ye, Ting .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (12) :1974-1983
[22]   Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review [J].
Jacobsen, Margo M. ;
Silverstein, Sophie C. ;
Quinn, Michael ;
Waterston, Leo B. ;
Thomas, Christian A. ;
Benneyan, James C. ;
Han, Paul K. J. .
LUNG CANCER, 2017, 112 :156-164
[23]   Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer [J].
Cheng, Chen ;
Wang, Zhifeng ;
Ding, Chao ;
Liu, Pingli ;
Xu, Xiaoqiang ;
Li, Yan ;
Yan, Yi ;
Yin, Xiaocong ;
Chen, Bi ;
Gu, Bing .
PHENOMICS, 2024, 4 (02) :125-137
[24]   IMPACT OF LUNG NODULE CLINIC IN TIMELINESS OF LUNG CANCER, DIAGNOSIS AND TREATMENT [J].
Howard, Guillermo J. Arias ;
Palomino, Jaime .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S1400-S1400
[25]   Wait times for diagnosis and treatment of lung cancer: a single-centre experience [J].
Labbe, C. ;
Anderson, M. ;
Simard, S. ;
Tremblay, L. ;
Laberge, F. ;
Vaillancourt, R. ;
Lacasse, Y. .
CURRENT ONCOLOGY, 2017, 24 (06) :367-373
[26]   Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment [J].
Hsu, Ming-Tsung ;
Wang, Yu-Ke ;
Tseng, Yufeng Jane .
CANCERS, 2022, 14 (03)
[27]   Molecular Markers in Guiding Lung Cancer Diagnosis and Treatment [J].
Li, Vivian ;
Vigneswaran, Wickii T. .
JOURNAL OF MENS HEALTH, 2022, 18 (08)
[28]   Interventional radiology in lung cancer: from diagnosis to treatment [J].
Gangi, A. ;
Buy, X. .
REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) :S137-S145
[29]   Pulmonary perspective: immunology in diagnosis and treatment of lung cancer [J].
Weynants, P ;
Marchandise, FX ;
Sibille, Y .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (08) :1703-1719
[30]   Evaluation and management of the complications of lung cancer treatment [J].
Ah-See, MLW ;
Spiro, SG .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 21 (05) :451-462